Submitted December 21, 2010 - USP Comment Letter to FDA on Approval Pathway for Biosimilar and Interchangeable Biological Products (2010). Docket No. FDA-2010-N0477.
USP-Biosimilar-Comments-to-FDA.pdf
(264.76 KB)
Submitted December 21, 2010 - USP Comment Letter to FDA on Approval Pathway for Biosimilar and Interchangeable Biological Products (2010). Docket No. FDA-2010-N0477.